Deep vein thrombosis and pulmonary embolism are serious side effects of Janus kinase inhibitors.

We analyzed spontaneous reports of adverse events from people of Japanese ethnicity, who are known to have a lower incidence of thrombosis.

Some JAK inhibitors may increase the risk of DVT in Japanese patients, warranting cautious use.